BRIEF published on 05/06/2024 at 23:30, 6 months 14 days ago Jolt Health Inc. acquiert la technologie révolutionnaire de patch transdermique HCQ Approbation De La FDA Jolt Santé Inc. Hydroxychloroquine Technologie Des Patchs Transdermiques Actifs Biotechnologiques
PRESS RELEASE published on 05/06/2024 at 23:25, 6 months 14 days ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 7 months 24 days ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 7 months 24 days ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 7 months 24 days ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 8 months 12 days ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 8 months 12 days ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 8 months 12 days ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 1 year 8 months ago Love Pharma Inc. Announces Share Consolidation
Published on 11/21/2024 at 11:30, 30 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 57 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 3 hours ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 25 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 11:30, 30 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 59 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 1 hour ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 1 hour 3 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 30 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 06:58, 5 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 2 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 53 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
